<DOC>
	<DOCNO>NCT02870010</DOCNO>
	<brief_summary>Chemoembolization recognize treatment strategy hepatocellular carcinoma ( HCC ) - classical chemoembolization consist inject emulsion anticancer agent Lipiodol® via hepatic artery - doxorubicin , anthracycline , frequently use drug lipiodol chemoembolization ( LCE ) - however , less half HCC respond favourably classical lipiodol chemoembolization ( LCE ) doxorubicin/Lipiodol® In trial , propose introduce clinical practice strategy base idarubicin achieve effective antitumor effect follow reason , recently point team : - idarubicin anthracycline penetrate tumour cell quickly cytotoxic doxorubicin hepatocellular carcinoma cell line - idarubicin injected solution embolization microspheres diameter ( 300-500µm ) , progressive control release anticancer drug , whereas doxorubicin/Lipiodol® emulsion unstable</brief_summary>
	<brief_title>Chemoembolization Non-resectable Non-metastatic Hepatocellular Carcinoma Using Embolization Microspheres</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Idarubicin</mesh_term>
	<criteria>Hepatocellular carcinoma ( HCC ) proven cytology histology diagnosis accord 2005 criteria American Association Study Liver Diseases , ( AASLD ) , require presence histological unequivocal cirhosis accord size nodule : nodule &lt; 1 cm : increase size accord US scan every 34 month nodule 1 2 cm : 2 concordant image technique : CTscan , MRI , contrastenhanced US ( CEUS ) ; diagnosis Hepatocellular carcinoma ( HCC ) presence typical image ( hypervascularized arterial + washout phase ) 2 image method ; case , biopsy . nodule &gt; 2 cm : CTscan MRI CEUS ( 1 technique ) ; diagnosis Hepatocellular carcinoma ( HCC ) presence hypervascularization associate either washout image alphafoetoprotein &gt; 200 µg/L ; case , biopsy . A maximum 3 nodule ( Singlelobe disease limit number nodule , bilobar disease maximum 3 nodule ) distribute throughout liver detect liver MRI injection Gadolinium chelate , date back less 1 month . In case contraindication MRI ( pacemaker , metallic intraocular foreign body , certains cardiac valve et certains intracranial clip ) , CTscan without iodinebased contrast ) . case cirrhosis : ChildPugh stage A B 7 without ascites , icterus WHO perfomance status 0 , 1 Platelets &gt; 50 000/mm3 , Polynuclear neutrophils &gt; 1000/mm3 Creatininemia &lt; 150 µmol/l Absence heart failure ( isotopic US LVEF &gt; 50 % ) Age &gt; 18 year Written inform consent Patients able undergo surgical resection liver transplantation local treatment radiofrequency ablation Extrahepatic metastasis ( lung , bone , peritoneum ... ) Digestive haemorrhage date back less one month Patients anticoagulant Portal thrombosis occur one segmental branch hepatofugal flow Doppler Pregnant woman Uncontrolled infection Hypersensitivity anthracyclines Hypersensitivity iodine contrast agent Patients guardianship</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>